Department of Anesthesiology, 129263University of Colorado Denver, Denver, CO, USA.
Semin Cardiothorac Vasc Anesth. 2022 Jun;26(2):120-128. doi: 10.1177/10892532221100663. Epub 2022 May 9.
This year marked a number of milestones in critical care. As vaccines for the SARS-CoV-2 virus became widely available and were confirmed to be exceptionally effective against severe illness and hospitalization, we were then faced with new variants and the resource-intense responses necessary to combat them. Despite challenges new and old, we have persevered and continued to provide excellent care to our patients while pushing the boundaries of clinical research. This article is a collection of studies published in 2021 relevant to critical care, with a specific focus on cardiothoracic critical care. To ignore the impact of the COVID-19 pandemic would do a disservice to our colleagues, many of whom have made incredible breakthroughs in novel therapies to the coronavirus, and yet we present additional themes of delirium, acute kidney injury, lung transplant, advances in ECMO as well as biomarkers of sepsis.
今年是重症监护领域的多个里程碑之年。随着针对 SARS-CoV-2 病毒的疫苗广泛应用,并被证实对严重疾病和住院治疗具有极高的有效性,我们又面临着新的变异株和应对这些变异株所需的资源密集型措施。尽管面临新旧挑战,我们仍坚持不懈,继续为患者提供卓越的护理,同时推动临床研究的发展。本文是对 2021 年发表的与重症监护相关的研究的汇总,重点关注心胸重症监护。如果忽视 COVID-19 大流行的影响,将是对我们同事们的不公,他们中的许多人在冠状病毒的新疗法方面取得了令人难以置信的突破,但我们还提出了其他主题,包括谵妄、急性肾损伤、肺移植、ECMO 的进展以及脓毒症的生物标志物。